Purchases and Sales Made in Q1 2022 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q1 2022. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 11, 2022
Q1 2022
|
Ronit Capital LLP
|
BUY
|
- |
550KNew |
$1.79M - $5.01M
|
550K
$2.59M
|
|
|
May 13, 2022
Q1 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
14.8KNew |
$48.2K - $135K
|
14.8K
$69.7K
|
|
|
May 17, 2022
Q1 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
11.4KNew |
$36.9K - $103K
|
11.4K
$53.4K
|
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
7.87KNew |
$25.6K - $71.6K
|
7.87K
$37K
|
|
|
May 12, 2022
Q1 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.75KNew |
$5.69K - $15.9K
|
1.75K
$8.23K
|
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
BUY
|
- |
141New |
$458 - $1.28K
|
141
$663
|
|
|
May 16, 2022
Q1 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
20New |
$65 - $182
|
20
$94
|
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|